Jinghui Zhan

AMG 757, a Half-Life Extended, DLL3-Targeted Bispecific T-Cell Engager, Shows High Potency and Sensitivity in Preclinical Models of Small-Cell Lung Cancer

Michael J. Giffin, Keegan S. Cooke, Edward K. Lobenhofer et al. · Clinical Cancer Research · 2020 · 238 citations · Full text

Medicine, Oncology, Pharmacology +15

Local Delivery of OncoVEXmGM-CSF Generates Systemic Antitumor Immune Responses Enhanced by Cytotoxic T-Lymphocyte–Associated Protein Blockade

Achim K. Moesta, Keegan S. Cooke, Julia Piasecki et al. · Clinical Cancer Research · 2017 · 105 citations

Life Sciences, Immunology, Oncology +17

AMG 509 (Xaluritamig), an Anti-STEAP1 XmAb 2+1 T-cell Redirecting Immune Therapy with Avidity-Dependent Activity against Prostate Cancer

Olivier Nolan-Stevaux, Cong Li, Lingming Liang et al. · Cancer Discovery · 2023 · 46 citations

Medicine, Immunology, Oncology +17

Tumor-specific intravenous gene delivery using oncolytic adenoviruses

Jinghui Zhan, Yi Gao, Wensheng Wang et al. · Cancer Gene Therapy · 2004 · 32 citations

Pharmacy, Cancer Biology, Oncology +14

Oxopyrido[2,3-<i>d</i>]pyrimidines as Covalent L858R/T790M Mutant Selective Epidermal Growth Factor Receptor (EGFR) Inhibitors

Ryan P. Wurz, Liping H. Pettus, Kate Ashton et al. · ACS Medicinal Chemistry Letters · 2015 · 22 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +14